Clinical Trials Browser

Phase 2 × Depression × Mirtazapine × Clear all

NCT02650544 2016-01-08

Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Depression